Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-inflammatory therapeutics are drugs used to treat inflammation that occurs after tissues are injured. There are two types of anti-inflammatory therapeutics: one is steroidal anti-inflammatory therapeutics, and the other is non-steroidal anti-inflammatory therapeutics, which are antipyretic and analgesic anti-inflammatory therapeutics referred to in medical practice, such as aspirin.
There are many inflammations that have not yet found a suitable diagnosis and treatment method. The intake of anti-inflammatory therapeutics can greatly reduce the pain caused by inflammation, and the cost is less than that of surgery. However, taking anti-inflammatory therapeutics will bring certain side effects, which hinders the development of the market to a certain extent.
The increasing incidence of chronic inflammation and autoimmune diseases has increased the demand for anti-inflammatory therapeutics. In addition, it is expected that the increasing awareness of anti-inflammatory therapeutics and the active measures of governments in the Asia-Pacific region will drive market growth. The research and development of new anti-inflammatory therapeutics by major developers in the market provides opportunities for the development of the anti-inflammatory therapeutics market.
This report elaborates on the current development of the Anti-inflammatory Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
GlaxoSmithKline plc
Eli Lily and Company
Johnson & Johnson
AstraZeneca PLC
Novartis AG
Amgen Inc
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Corticosteroids
Biologics
Other
Application:
Arthritis
Psoriasis
Respiratory Disease
Multiple Sclerosis
Inflammatory Bowel Disease
Other Inflammatory Disease
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Anti-inflammatory Therapeutics Industry Overview
-
1.1.1 Anti-inflammatory Therapeutics Market Scope and Market Segments
-
1.1.2 Anti-inflammatory Therapeutics Industry Characteristics
-
1.1.3 Global and China Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Anti-inflammatory Therapeutics Production Value and Growth Rate (2017-2028)
-
1.2 Global Anti-inflammatory Therapeutics Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
-
1.2.2 Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
-
1.2.3 Corticosteroids
-
1.2.4 Biologics
-
1.2.5 Other
-
1.3 Global Anti-inflammatory Therapeutics Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Arthritis
-
1.3.2 Psoriasis
-
1.3.3 Respiratory Disease
-
1.3.4 Multiple Sclerosis
-
1.3.5 Inflammatory Bowel Disease
-
1.3.6 Other Inflammatory Disease
-
1.4 Market Analysis by Region
-
1.4.1 North America Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Anti-inflammatory Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Anti-inflammatory Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Anti-inflammatory Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Anti-inflammatory Therapeutics Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Anti-inflammatory Therapeutics Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Anti-inflammatory Therapeutics Industry Porter's Five Forces Model Analysis
-
2.2.3 Anti-inflammatory Therapeutics Industry PEST Analysis
-
2.3 Anti-inflammatory Therapeutics Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Anti-inflammatory Therapeutics Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Anti-inflammatory Therapeutics Industry
Chapter 3 Global and China Anti-inflammatory Therapeutics Market, by Manufacturer
-
3.1 Global and China Anti-inflammatory Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Anti-inflammatory Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Anti-inflammatory Therapeutics Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Anti-inflammatory Therapeutics Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Anti-inflammatory Therapeutics Market Top 3 Players
Chapter 4 Global and China Anti-inflammatory Therapeutics Market, by Type (2017-2028)
-
4.1 Anti-inflammatory Therapeutics Market Trend, by Type
-
4.2 Global Anti-inflammatory Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Anti-inflammatory Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Anti-inflammatory Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Anti-inflammatory Therapeutics Price Trend, by Type (2017-2028)
-
4.3 China Anti-inflammatory Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Anti-inflammatory Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Anti-inflammatory Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Anti-inflammatory Therapeutics Price Trend, by Type (2017-2028)
Chapter 5 Global and China Anti-inflammatory Therapeutics Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Anti-inflammatory Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Anti-inflammatory Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Anti-inflammatory Therapeutics Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Anti-inflammatory Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Anti-inflammatory Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Anti-inflammatory Therapeutics Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Anti-inflammatory Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Anti-inflammatory Therapeutics Market Analysis
-
7.1 North America Anti-inflammatory Therapeutics Market, by Type
-
7.2 North America Anti-inflammatory Therapeutics Market, by Application
-
7.3 North America Anti-inflammatory Therapeutics Market Analysis and Forecast, by Country
-
7.3.1 United States Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Anti-inflammatory Therapeutics Market Analysis
-
8.1 Europe Anti-inflammatory Therapeutics Market, by Type
-
8.2 Europe Anti-inflammatory Therapeutics Market, by Application
-
8.3 Europe Anti-inflammatory Therapeutics Market Analysis and Forecast, by Country
-
8.3.1 Germany Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Anti-inflammatory Therapeutics Market Analysis
-
9.1 APAC Anti-inflammatory Therapeutics Market, by Type
-
9.2 APAC Anti-inflammatory Therapeutics Market, by Application
-
9.3 APAC Anti-inflammatory Therapeutics Market Analysis and Forecast, by Country
-
9.3.1 China Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Anti-inflammatory Therapeutics Market Analysis
-
10.1 Latin America, Middle East and Africa Anti-inflammatory Therapeutics Market, by Type
-
10.2 Latin America, Middle East and Africa Anti-inflammatory Therapeutics Market, by Application
-
10.3 Latin America, Middle East and Africa Anti-inflammatory Therapeutics Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Anti-inflammatory Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Anti-inflammatory Therapeutics Company Profiles
-
11.1 GlaxoSmithKline plc
-
11.1.1 GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 GlaxoSmithKline plc Anti-inflammatory Therapeutics Product Profiles, Application and Specification
-
11.1.3 GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Eli Lily and Company
-
11.2.1 Eli Lily and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Eli Lily and Company Anti-inflammatory Therapeutics Product Profiles, Application and Specification
-
11.2.3 Eli Lily and Company Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Johnson & Johnson
-
11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Profiles, Application and Specification
-
11.3.3 Johnson & Johnson Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 AstraZeneca PLC
-
11.4.1 AstraZeneca PLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Profiles, Application and Specification
-
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Novartis AG
-
11.5.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Novartis AG Anti-inflammatory Therapeutics Product Profiles, Application and Specification
-
11.5.3 Novartis AG Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Amgen Inc
-
11.6.1 Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Amgen Inc Anti-inflammatory Therapeutics Product Profiles, Application and Specification
-
11.6.3 Amgen Inc Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Anti-inflammatory Therapeutics Industry Investment Prospect and Risk Assessment
-
12.1 Anti-inflammatory Therapeutics Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Anti-inflammatory Therapeutics Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Nonsteroidal Anti-inflammatory Diseases (NSAIDs) (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Immune Selective Anti-inflammatory Derivatives (ImSAIDs) (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Corticosteroids (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Biologics (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Arthritis (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Psoriasis (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Respiratory Disease (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Multiple Sclerosis (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Market Size and Growth Rate of Other Inflammatory Disease (2017-2028)
-
Figure North America Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-inflammatory Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Anti-inflammatory Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Anti-inflammatory Therapeutics Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Anti-inflammatory Therapeutics Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Anti-inflammatory Therapeutics Market Share, by Manufacturer in 2021
-
Figure Global and China Anti-inflammatory Therapeutics Market Share, by Manufacturer in 2022
-
Table Global Anti-inflammatory Therapeutics Sales Volume, by Type (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Sales Value, by Type (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Price Trend, by Type (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Volume, by Type (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Value, by Type (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Price Trend, by Type (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Sales Volume, by Application (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Sales Value, by Application (2017-2028)
-
Table Global Anti-inflammatory Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure Global Anti-inflammatory Therapeutics Sales Value Share, by Application (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Volume, by Application (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Value, by Application (2017-2028)
-
Table China Anti-inflammatory Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure North America Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Anti-inflammatory Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Table North America Anti-inflammatory Therapeutics Sales Volume, by Type (2017-2028)
-
Table North America Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure North America Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table North America Anti-inflammatory Therapeutics Sales Volume, by Application (2017-2028)
-
Table North America Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure North America Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure United States Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure United States Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Canada Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Europe Anti-inflammatory Therapeutics Sales Volume, by Type (2017-2028)
-
Table Europe Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Europe Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Europe Anti-inflammatory Therapeutics Sales Volume, by Application (2017-2028)
-
Table Europe Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Europe Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Germany Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure UK Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure UK Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure France Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure France Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Italy Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Spain Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Poland Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Russia Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table APAC Anti-inflammatory Therapeutics Sales Volume, by Type (2017-2028)
-
Table APAC Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure APAC Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table APAC Anti-inflammatory Therapeutics Sales Volume, by Application (2017-2028)
-
Table APAC Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure APAC Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Japan Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure India Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure India Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Anti-inflammatory Therapeutics Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-inflammatory Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-inflammatory Therapeutics Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-inflammatory Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Anti-inflammatory Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Anti-inflammatory Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline plc Product Profiles, Application and Specification
-
Table GlaxoSmithKline plc Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lily and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lily and Company Product Profiles, Application and Specification
-
Table Eli Lily and Company Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca PLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca PLC Product Profiles, Application and Specification
-
Table AstraZeneca PLC Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis AG Product Profiles, Application and Specification
-
Table Novartis AG Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Inc Product Profiles, Application and Specification
-
Table Amgen Inc Anti-inflammatory Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
